James J Hsieh

Citée par

	Toutes	Depuis 2020
Citations	33061	18714
indice h	83	62
indice i10	164	147

4100

2050

1025

3075

1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202595 92 127 165 231 159 194 202 185 189 279 308 315 422 527 488 627 890 1112 1430 1733 1901 2398 3199 3797 4044 3745 3407 476

Accès public

Tout afficher

133 articles

10 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Han LiuShanghai Institute of HematologyAdresse e-mail validée de sjtu.edu.cn
Chris SanderHarvard Medical School, Broad Institute, MGH, Dana-Farber Cancer Institute, Memorial Sloan KetteringAdresse e-mail validée de sanderlab.org
Irina OstrovnayaAssociate Attending Biostatistician, MSKCCAdresse e-mail validée de mskcc.org
Ho-Chou TuAlnylam PharmaceuticalsAdresse e-mail validée de alnylam.com
William LeeMemorial Sloan Kettering Cancer CenterAdresse e-mail validée de mskcc.org
Sabina SignorettiProfessor, Brigham and Women's Hospital, Harvard Medical SchoolAdresse e-mail validée de bwh.harvard.edu
Anders Jacobsen SkanderupGenome Institute of SingaporeAdresse e-mail validée de gis.a-star.edu.sg
Sujata PatilCleveland ClinicAdresse e-mail validée de ccf.org
Ed ReznikMemorial Sloan Kettering Cancer CenterAdresse e-mail validée de mskcc.org
W. Kimryn RathmellFormer Director, National Cancer InstituteAdresse e-mail validée de nih.gov
Nikolaus SchultzCenter for Molecular Oncology, Memorial Sloan Kettering Cancer CenterAdresse e-mail validée de cbio.mskcc.org
Mithat GönenMemorial Sloan-Kettering Cancer CenterAdresse e-mail validée de alumni.stanford.edu
Satoru SasagawaResearch Institute, Nozaki Tokushukai HospitalAdresse e-mail validée de tokushukai.jp
Emily C. ZaborAssociate Staff (Faculty), Cleveland Clinic Department of Quantitative Health SciencesAdresse e-mail validée de ccf.org
Chad CreightonProfessor of Medicine, Baylor College of MedicineAdresse e-mail validée de bcm.edu
David Y. ChenAssistant Professor of Medicine, Washington UniversityAdresse e-mail validée de wustl.edu
Andrew WinerAssistant professor of urology, SUNY Downstate Medical SchoolAdresse e-mail validée de downstate.edu
James LarkinRoyal Marsden Hospital / Institute of Cancer Research, London, UKAdresse e-mail validée de rmh.nhs.uk
Michael F BergerMember, Memorial Sloan-Kettering Cancer CenterAdresse e-mail validée de mskcc.org
Jodi MaranchieAssistant Professor, Universitiy of PittsburghAdresse e-mail validée de upmc.edu

Suivre

James J Hsieh

Washington University in St. Louis

Adresse e-mail validée de wustl.edu - Page d'accueil

Integrated Precision Oncology Immunotherapy Kidney Cancer Integrated Spatiotemporal Multi-Omics Innovative Mechanism-Based R


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Comprehensive molecular characterization of clear cell renal cell carcinoma Cancer Genome Atlas Research Network Analysis working group: Baylor College ... Nature 499 (7456), 43-49, 2013	2998	2013
Renal cell carcinoma JJ Hsieh, MP Purdue, S Signoretti, C Swanton, L Albiges, M Schmidinger, ... Nature reviews Disease primers 3 (1), 1-19, 2017	2542	2017
Nivolumab plus cabozantinib versus sunitinib for advanced renal-cell carcinoma TK Choueiri, T Powles, M Burotto, B Escudier, MT Bourlon, B Zurawski, ... New England Journal of Medicine 384 (9), 829-841, 2021	1480	2021
Comprehensive molecular characterization of papillary renal-cell carcinoma Cancer Genome Atlas Research Network New England Journal of Medicine 374 (2), 135-145, 2016	1269	2016
Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies H Kim, M Rafiuddin-Shah, HC Tu, JR Jeffers, GP Zambetti, JJD Hsieh, ... Nature cell biology 8 (12), 1348-1358, 2006	1115	2006
The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma CJ Ricketts, AA De Cubas, H Fan, CC Smith, M Lang, E Reznik, R Bowlby, ... Cell reports 23 (1), 313-326. e5, 2018	918	2018
The somatic genomic landscape of chromophobe renal cell carcinoma CF Davis, CJ Ricketts, M Wang, L Yang, AD Cherniack, H Shen, C Buhay, ... Cancer cell 26 (3), 319-330, 2014	869	2014
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures Y Şenbabaoğlu, RS Gejman, AG Winer, M Liu, EM Van Allen, ... Genome biology 17, 1-25, 2016	858	2016
Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal S Turajlic, H Xu, K Litchfield, A Rowan, T Chambers, JI Lopez, D Nicol, ... Cell 173 (3), 581-594. e12, 2018	787	2018
Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis H Kim, HC Tu, D Ren, O Takeuchi, JR Jeffers, GP Zambetti, JJD Hsieh, ... Molecular cell 36 (3), 487-499, 2009	728	2009
An integrated metabolic atlas of clear cell renal cell carcinoma AA Hakimi, ED Reznik, CH Lee, CJ Creighton, AR Brannon, A Luna, ... Cancer cell 29 (1), 104-116, 2016	720	2016
Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 179 (4), 964-983. e31, 2019	595	2019
Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2 JJD Hsieh, T Henkel, P Salmon, E Robey, MG Peterson, SD Hayward Molecular and cellular biology 16 (3), 952-959, 1996	568	1996
BID, BIM, and PUMA are essential for activation of the BAX-and BAK-dependent cell death program D Ren, HC Tu, H Kim, GX Wang, GR Bean, O Takeuchi, JR Jeffers, ... Science 330 (6009), 1390-1393, 2010	563	2010
Notch signaling inhibits muscle cell differentiation through a CBF1-independent pathway C Shawber, D Nofziger, JJD Hsieh, C Lindsell, O Bögler, D Hayward, ... Development 122 (12), 3765-3773, 1996	496	1996
The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ... Cell 181 (2), 236-249, 2020	463	2020
Masking of the CBF1/RBPJ_κ Transcriptional Repression Domain by Epstein-Barr Virus EBNA2 JJD Hsieh, SD Hayward Science 268 (5210), 560-563, 1995	413	1995
CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex JJD Hsieh, S Zhou, L Chen, DB Young, SD Hayward Proceedings of the National Academy of Sciences 96 (1), 23-28, 1999	409	1999
Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network AA Hakimi, I Ostrovnaya, B Reva, N Schultz, YB Chen, M Gonen, H Liu, ... Clinical Cancer Research 19 (12), 3259-3267, 2013	405	2013
Proteogenomic characterization of endometrial carcinoma Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ... Cell 180 (4), 729-748. e26, 2020	382	2020

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs